Dahu Health Industry Co (SHSE:600257) Long-Term Debt: ¥106.4 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600257 Dahu Health Industry Co Ltd SHSE:600257
47 GF Score
Price ¥5.49
GF Value ¥4.45
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Dahu Health Industry Co Long-Term Debt?

Dahu Health Industry Co SHSE:600257 +1.48% 47 Long-Term Debt is ¥106.4 Mil as of Jun. 2026. GuruFocus rates SHSE:600257 with a GF Score™ of 47/100 and a GF Value™ of ¥4.45 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Dahu Health Industry Co's Long-Term Debt for the quarter that ended in Jun. 2026 was ¥106.4 Mil.

Dahu Health Industry Co's quarterly Long-Term Debt increased from Dec. 2025 (¥44.5 Mil) to Mar. 2026 (¥93.0 Mil) and increased from Mar. 2026 (¥93.0 Mil) to Jun. 2026 (¥106.4 Mil).

Dahu Health Industry Co's annual Long-Term Debt declined from Dec. 2023 (¥139.2 Mil) to Dec. 2024 (¥68.5 Mil) and declined from Dec. 2024 (¥68.5 Mil) to Dec. 2025 (¥44.5 Mil).

Dahu Health Industry Co  (SHSE:600257) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Dahu Health Industry Co Long-Term Debt Related Terms

Dahu Health Industry Co Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Dahu Health Industry Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dahu Health Industry Co Long-Term Debt Chart

Dahu Health Industry Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 167.50 147.50 139.20 68.50 44.48

Dahu Health Industry Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.50 46.50 44.48 92.95 106.44
SHSE:600257
47GF Score
Dahu Health Industry Co Ltd SHSE:600257
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ¥106.4 Mil mean?
Dahu Health Industry Co (SHSE:600257) has a Long-Term Debt of ¥106.4 Mil as of Jun. 2026.
Is Dahu Health Industry Co's Long-Term Debt too high?
Dahu Health Industry Co's current Long-Term Debt is ¥106.4 Mil. Overall, Dahu Health Industry Co has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dahu Health Industry Co's Long-Term Debt compare to ADM and BG?
Dahu Health Industry Co's Long-Term Debt of ¥106.4 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Consumer Packaged Goods company?
A good Long-Term Debt depends on the Consumer Packaged Goods industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Dahu Health Industry Co's current Long-Term Debt is ¥106.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dahu Health Industry Co stock overvalued right now?
Based on GuruFocus' analysis, Dahu Health Industry Co (SHSE:600257) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥4.45, compared to a current price of ¥5.49 — trading 23.4% above its estimated fair value. The current Long-Term Debt is ¥106.4 Mil. Dahu Health Industry Co's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Dahu Health Industry Co (SHSE:600257), the current Long-Term Debt is ¥106.4 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dahu Health Industry Co (SHSE:600257) Overvalued in 2026?

Based on GuruFocus' analysis, Dahu Health Industry Co stock appears to be overvalued. The current stock price of ¥5.49 is trading 23.4% above its estimated GF Value™ of ¥4.45. GuruFocus considers Dahu Health Industry Co to be Modestly Overvalued.

Key valuation signals for SHSE:600257:

  • Long-Term Debt: ¥106.4 Mil
  • GF Value™: ¥4.45 vs. price of ¥5.49 (23.4% above fair value)
  • GF Score™: 47/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600257 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dahu Health Industry Co Business Description

Address Jianmin Lane Community Construction East Road, No. 348, Danyang Street, Wuling District, Hunan Province, Changde, CHN, 415000
Dahu Health Industry Co Ltd engages in aquatic products and waterfowl breeding, processing, and comprehensive development, alongside foreign investment in proprietary Chinese medicine production and sales. Its operations include medical and food production and sales, nursing, hospital, elderly care, and health services. It also provides artificial intelligence-related technical consulting and system integration, and sells consumer robots.
47GF Score

Get the complete analysis for SHSE:600257

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.49
Price
¥4.45
GF Value